The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
Discover how Mounjaro the revolutionary weight-loss and diabetes drug by Eli Lilly is set to transform obesity management in ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar ...
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
“While no drug is without side effects, health problems associated with obesity almost certainly exceed the risks of GLP-1 ...
He also revealed in a separate post he is taking the weight-loss drug Mounjaro. (X/@elonmusk) The mega-billionaire, who Trump has tapped to lead the government efficiency advisory committee ...
UBS does not expect biopharma sector to outperform in 2025. Its analysts still see GLP-1 theme dominating the space next year ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...